SwedenLivingWorldBusinessSportsEntertainment

Bioarctics

Alzheimer's drug rejected by EMA

The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks.
Alzheimer's drug rejected by EMA
Show Consent Options

Categories

Information

About Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald